Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,372 | -7,345 | -4,682 | -8,044 | -16,675 |
| Depreciation Amortization | 728 | 776 | 1,199 | 1,071 | 882 |
| Income taxes - deferred | -200 | N/A | N/A | -149 | N/A |
| Accounts receivable | 241 | 590 | 1,337 | -2,992 | 21 |
| Accounts payable and accrued liabilities | 1,156 | -292 | 68 | 432 | -450 |
| Other Working Capital | 1,640 | 252 | 58 | -2,860 | -981 |
| Other Operating Activity | -1,108 | 1,218 | -4,695 | 3,922 | 768 |
| Operating Cash Flow | $-5,916 | $-4,802 | $-6,715 | $-8,621 | $-16,435 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -9 | -712 |
| Net Acquisitions | N/A | N/A | N/A | -5,350 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -6 | -4 |
| Other Investing Activity | 0 | 1,687 | 116 | -6 | -4 |
| Investing Cash Flow | $N/A | $1,687 | $116 | $-5,366 | $-716 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,152 | 2,729 | N/A | N/A | 1,170 |
| Other Financing Activity | 0 | 0 | 0 | -14 | -97 |
| Financing Cash Flow | $8,152 | $2,729 | $N/A | $-14 | $1,073 |
| Exchange Rate Effect | N/A | 12 | 9 | -323 | 1,100 |
| Beginning Cash Position | 3,649 | 4,260 | 11,207 | 25,220 | 60,873 |
| End Cash Position | 5,885 | 3,886 | 4,618 | 10,898 | 45,894 |
| Net Cash Flow | $2,236 | $-374 | $-6,589 | $-14,323 | $-14,978 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,916 | -4,802 | -6,715 | -8,621 | -16,435 |
| Capital Expenditure | N/A | N/A | N/A | -9 | -716 |
| Free Cash Flow | -5,916 | -4,802 | -6,715 | -8,630 | -17,152 |